Marked Variation in Hepatic Steatosis in Metabolic Dysfunction‐Associated Steatotic Liver Disease Over 5 Years: A Community‐Based Study Using Controlled Attenuation Parameter

There is marked variation in liver fat content among participants from the general population over a period of 5 years, indicating its dynamic nature. These variations should be considered in epidemiological studies of MASLD.

Authors

Institutions

Publication Details

Journal
United European Gastroenterology Journal
Published
2025-10-08
DOI
https://doi.org/10.1002/ueg2.70099
Citations
1
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
1.35

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Marked Variation in Hepatic Steatosis in Metabolic Dysfunction‐Associated Steatotic Liver Disease Over 5 Years: A Community‐Based Study Using Controlled Attenuation Parameter

Elisa Pose, Rosario Lunar Hernández, Marta Cervera, Adrià Juanola et al.
1 citations
United European Gastroenterology Journal
Liver Disease Diagnosis and Treatment
1.35
article

Marked Variation in Hepatic Steatosis in Metabolic Dysfunction‐Associated Steatotic Liver Disease Over 5 Years: A Community‐Based Study Using Controlled Attenuation Parameter

Elisa Pose, Rosario Lunar Hernández, Marta Cervera, Adrià Juanola, Anna Sòria, Núria Fabrellas, Isabel Graupera, Gemma Sáez, Pere Ginès, Ruth Nadal, Queralt Herms, Maria Sanz‐Rodríguez, Martina Pérez, Marta Carol, Míriam Pellón
article en
1 citations

Abstract

There is marked variation in liver fat content among participants from the general population over a period of 5 years, indicating its dynamic nature. These variations should be considered in epidemiological studies of MASLD.

United European Gastroenterology JournalVol. 13(10)
Departament de Salut (ES), Hospital Clínic de Barcelona (ES), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (ES), Institut Català de la Salut (ES), Fundació Clínic per a la Recerca Biomèdica (ES), Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES), Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer (ES), Universitat de Barcelona (ES)
European Commission, Horizon 2020 Framework Programme, Instituto de Salud Carlos III, European Regional Development Fund
Openalex Percentile: Top 15%
Liver Disease Diagnosis and Treatment
1.35
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.